Study: Drug combo may improve ovarian cancer patients' survival

11/15/2006 | Reuters

An international research team says a combination of two types of cancer drugs, platinums and taxanes, may extend survival for patients with ovarian cancer when injected into the abdominal cavity. The scientists reviewed studies of ovarian cancer involving more than 15,000 patients to identify the most effective chemotherapy combinations.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC